Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells
- PMID: 16289236
- DOI: 10.1016/j.lfs.2005.09.036
Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells
Abstract
Fibrinolytic factors have an important role in tumor progression through the degradation of extracellular matrix. The increased levels of urokinase-type plasminogen activator (uPA), uPA-receptor (uPAR) and type-1 PA inhibitor (PAI-1) are reported in human renal cell carcinoma (RCC). Connexin (Cx) gene, a member of gap junction, is known to act as a tumor suppressor gene. We have reported that Cx32 improves malignant phenotypes of metastatic RCC cells via the inhibition of Src-dependent signaling. In this study, we examined the effect of expression of Cx32 gene on the production of uPA, uPAR and PAI-1, and on the induction of PAI-1 stimulated by hypoxia in a human metastatic RCC cell line, Caki-1 cells. Cx32 expression decreased both mRNA level and production of PAI-1, uPA and uPAR in Caki-1 cells. Cx32 also decreased hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha mRNA level. PP1, a Src inhibitor, significantly decreased PAI-1, uPA, uPAR and HIF-alpha mRNA levels in Caki-1 cells. Furthermore, Cx32 suppressed the induction of HIF-2alpha protein in Caki-1 cells under hypoxia. PAI-1 mRNA level in Cx32-transfected Caki-1 cells was lower than that of mock transfectant under hypoxic conditions. These results suggest that Cx32 might reduce PAI-1, uPA and uPAR production in metastatic RCC cells via the inhibition of Src-dependent induction of HIF-1alpha and HIF-2alpha gene expression and that Cx32 might suppress hypoxia-inducible gene expression under hypoxic conditions.
Similar articles
-
The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.Mol Carcinog. 2008 Jun;47(6):403-9. doi: 10.1002/mc.20396. Mol Carcinog. 2008. PMID: 18058801
-
Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.Oncol Rep. 2005 Sep;14(3):777-82. Oncol Rep. 2005. PMID: 16077991
-
Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.J Urol. 2005 Aug;174(2):461-5. doi: 10.1097/01.ju.0000165150.46006.92. J Urol. 2005. PMID: 16006865
-
Urokinase-type plasminogen activator system and breast cancer (Review).Oncol Rep. 2005 Jul;14(1):105-12. Oncol Rep. 2005. PMID: 15944776 Review.
-
Evolving role of uPA/uPAR system in human cancers.Cancer Treat Rev. 2008 Apr;34(2):122-36. doi: 10.1016/j.ctrv.2007.10.005. Epub 2007 Dec 26. Cancer Treat Rev. 2008. PMID: 18162327 Review.
Cited by
-
The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective.Cell Mol Life Sci. 2020 Mar;77(5):819-833. doi: 10.1007/s00018-019-03422-9. Epub 2019 Dec 31. Cell Mol Life Sci. 2020. PMID: 31893312 Free PMC article. Review.
-
Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma.Br J Cancer. 2008 Mar 11;98(5):931-40. doi: 10.1038/sj.bjc.6604243. Epub 2008 Feb 19. Br J Cancer. 2008. PMID: 18283322 Free PMC article.
-
Comprehensive Pan-Cancer Analysis of Connexin 43 as a Potential Biomarker and Therapeutic Target in Human Kidney Renal Clear Cell Carcinoma (KIRC).Medicina (Kaunas). 2024 May 8;60(5):780. doi: 10.3390/medicina60050780. Medicina (Kaunas). 2024. PMID: 38792963 Free PMC article.
-
Regulation of connexins genes expression contributes to reestablishes tissue homeostasis in a renovascular hypertension model.Heliyon. 2020 Nov 2;6(11):e05406. doi: 10.1016/j.heliyon.2020.e05406. eCollection 2020 Nov. Heliyon. 2020. PMID: 33163681 Free PMC article.
-
Regulation of renal cell carcinoma cell proliferation, invasion and metastasis by connexin 32 gene.J Membr Biol. 2007 Mar;216(1):17-21. doi: 10.1007/s00232-007-9020-5. Epub 2007 Jun 13. J Membr Biol. 2007. PMID: 17565422 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous